Inventor · disambiguated record
Jianmin Fu
Also filed as: FU JIANMIN
58 granted patents·27 pending applications·520 citations·filing 2005–2022
98Inventor score
Files withXENON PHARMACEUTICALS INC30MERCK SHARP & DOHME23CHAFEEV MIKHAIL9DALES NATALIE8CADIEUX JEAN-JACQUES3
Top patents by PatentIndex Score
85 records- 0197US8883840B2Enantiomers of spiro-oxindole compounds and their uses as therapeutic agentsCHAFEEV MIKHAIL·Filed 2012·Granted Nov 11, 2014·63 cites·1 claims
- 0295US8466188B2Use of spiro-oxindole compounds as therapeutic agentsCHAFEEV MIKHAIL·Filed 2007·Granted Jun 18, 2013·63 cites·1 claims
- 0395US7700641B2Spiro-oxindole compounds and their uses as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2006·Granted Apr 20, 2010·39 cites·41 claims
- 0493US8450358B2Enantiomers of spiro-oxindole compounds and their uses as therapeutic agentsCHAFEEV MIKHAIL·Filed 2010·Granted May 28, 2013·17 cites·3 claims
- 0593US8101647B2Spiro-oxindole compounds and their use as therapeutic agentsCHAFEEV MIKHAIL·Filed 2009·Granted Jan 24, 2012·35 cites·37 claims
- 0693US7767677B2Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitorsXENON PHARMACEUTICALS INC·Filed 2005·Granted Aug 3, 2010·34 cites·10 claims
- 0792US7935721B2Spiro-oxindole compounds and their uses as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2009·Granted May 3, 2011·18 cites·15 claims
- 0892US7799798B2Spiroheterocyclic compounds and their uses as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2006·Granted Sep 21, 2010·26 cites·9 claims
- 0992US7592343B2Pyridazine-piperazine compounds and their use as stearoyl-CoA desaturase inhibitorsXENON PHARMACEUTICALS INC·Filed 2005·Granted Sep 22, 2009·22 cites·6 claims
- 1091US8263606B2Spiro-oxindole compounds and their use as therapeutic agentsCHAFEEV MIKHAIL·Filed 2009·Granted Sep 11, 2012·16 cites·25 claims
- 1191US8106087B2Spiro-oxindole compounds and their uses as therapeutic agentsCHAFEEV MIKHAIL·Filed 2009·Granted Jan 31, 2012·19 cites·6 claims
- 1291US7547698B2Bicyclic heterocyclic derivatives and their use as inhibitors of stearoyl-coadesaturase (SCD)XENON PHARMACEUTICALS INC·Filed 2005·Granted Jun 16, 2009·18 cites·9 claims
- 1390US10221163B2Metallo-beta-lactamase inhibitorsMERCK SHARP & DOHME·Filed 2016·Granted Mar 5, 2019·4 cites·67 claims
- 1489US8415370B2Spiro-oxindole compounds and their uses as therapeutic agentsCHAFEEV MIKHAIL·Filed 2012·Granted Apr 9, 2013·10 cites·13 claims
- 1588US7777036B2Heterocyclic derivatives and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2005·Granted Aug 17, 2010·13 cites·9 claims
- 1687US9777035B24′-substituted nucleoside reverse transcriptase inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Oct 3, 2017·10 cites·59 claims
- 1787US8742109B2Synthetic methods for spiro-oxindole compoundsCADIEUX JEAN-JACQUES·Filed 2012·Granted Jun 3, 2014·12 cites·6 claims
- 1886US8541457B2Aminothiazole derivatives as human stearoyl-CoA desaturase inhibitorsFU JIANMIN·Filed 2006·Granted Sep 24, 2013·16 cites·4 claims
- 1986US8258160B2SCD1 inhibitors triazole and tetrazole compoundsDALES NATALIE·Filed 2007·Granted Sep 4, 2012·11 cites·17 claims
- 2085US9808542B2Pyrrolo[2,3-C]pyridines as imaging agents for neurofibrillaryMERCK SHARP & DOHME·Filed 2015·Granted Nov 7, 2017·7 cites·37 claims
- 2185US9480677B2Enantiomers of spiro-oxindole compounds and their uses as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2014·Granted Nov 1, 2016·5 cites·1 claims
- 2285US8049016B2Thiazole derivatives which inhibit stearoyl-CoA desaturase enzymesNOVARTIS AG·Filed 2009·Granted Nov 1, 2011·7 cites·19 claims
- 2384US8445696B2Synthetic methods for spiro-oxindole compoundsCADIEUX JEAN-JACQUES·Filed 2010·Granted May 21, 2013·9 cites·8 claims
- 2483US10544130B2Metallo-beta-lactamase inhibitorsMERCK SHARP & DOHME·Filed 2019·Granted Jan 28, 2020·1 cites·20 claims
- 2583US8063084B2Heterocyclic compounds suitable for the treatment of diseases related to elevated lipid levelsDALES NATALIE·Filed 2007·Granted Nov 22, 2011·6 cites·14 claims
- 2682US9695185B2Synthetic methods for spiro-oxindole compoundsXENON PHARMACEUTICALS INC·Filed 2016·Granted Jul 4, 2017·3 cites·1 claims
- 2782US9487535B2Asymmetric syntheses for spiro-oxindole compounds useful as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2013·Granted Nov 8, 2016·5 cites·26 claims
- 2882US8916580B2Spiro-oxindole compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2013·Granted Dec 23, 2014·4 cites·8 claims
- 2980US10030027B2Soluble guanylate cyclase stimulatorsMERCK SHARP & DOHME·Filed 2016·Granted Jul 24, 2018·3 cites·56 claims
- 3079US9988397B2ERK inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Jun 5, 2018·2 cites·6 claims
- 3179US9260446B2Synthetic methods for spiro-oxindole compoundsXENON PHARMACEUTICALS INC·Filed 2014·Granted Feb 16, 2016·4 cites·5 claims
- 3278US10022461B2Pyrrolo[2,3-C]pyridines as imaging agents for neurofibrilary tanglesMERCK SHARP & DOHME·Filed 2017·Granted Jul 17, 2018·2 cites·3 claims
- 3378US8501746B2Organic compoundsDALES NATALIE·Filed 2007·Granted Aug 6, 2013·3 cites·16 claims
- 3478US8026360B2Substituted pyridazines as stearoyl-CoA desaturase inhibitorsXENON PHARMACEUTICALS INC·Filed 2009·Granted Sep 27, 2011·3 cites·5 claims
- 3577US10227331B2Metallo-β-lactamase inhibitorsMERCK SHARP & DOHME·Filed 2016·Granted Mar 12, 2019·1 cites·26 claims
- 3675US12187742B2Dual ATM and DNA-PK inhibitors for use in anti-tumor therapyXRAD THERAPEUTICS INC·Filed 2020·Granted Jan 7, 2025·1 cites·25 claims
- 3774US10160762B26-alkyl dihydropyrazolopyrimidinone compounds as PDE2 inhibitorsMERCK SHARP & DOHME·Filed 2016·Granted Dec 25, 2018·2 cites·17 claims
- 3873US9884048B2ERK inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Feb 6, 2018·2 cites·6 claims
- 3973US9458178B2Spiro-oxindole compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2014·Granted Oct 4, 2016·1 cites·4 claims
- 4072US7919496B2Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-CoA desaturase enzymesXENON PHARMACEUTICALS INC·Filed 2005·Granted Apr 5, 2011·1 cites·10 claims
- 4171US7829712B2Pyridazine derivatives for inhibiting human stearoyl-CoA-desaturaseXENON PHARMACEUTICALS INC·Filed 2005·Granted Nov 9, 2010·1 cites·16 claims
- 4264US9187426B2Organic compoundsDALES NATALIE·Filed 2009·Granted Nov 17, 2015·0 cites·2 claims
- 4363US10100064B2Purine inhibitors of human phosphatidylinositol 3-kinase deltaMERCK SHARP & DOHME·Filed 2015·Granted Oct 16, 2018·1 cites·11 claims
- 4456US2017114075A1Spiro-oxindole compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 4556US2021401957A1Robo1 car-nk cell carrying suicide gene, preparation method and application thereofASCLEPIUS SUZHOU TECH COMPANY GROUP CO LTD·Filed 2021·Application pending·0 cites
- 4655US2017073351A1Enantiomers of spiro-oxindole compounds and their uses as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 4754US8293768B2Organic compoundsDALES NATALIE·Filed 2011·Granted Oct 23, 2012·0 cites·2 claims
- 4853US2011269788A1Spiro-oxindole-derivatives as sodium channel blockersXENON PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 4953US2012122909A9Spiro-oxindole compounds and their uses as therapeutic agentsCHAFEEV MIKHAIL·Filed 2011·Application pending·0 cites
- 5051US11179389B2Purine inhibitors of human phosphatidylinositol 3-kinase deltaMERCK SHARP & DOHME·Filed 2018·Granted Nov 23, 2021·0 cites·13 claims
Showing the top 50 of 85 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Jianmin Fu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →